|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| (11) | Number of the document | 2068930 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07840744.2 |
| Date of filing the European patent application | 2007-08-07 | |
| (97) | Date of publication of the European application | 2009-06-17 |
| (45) | Date of publication and mention of the grant of the patent | 2012-09-19 |
| (46) | Date of publication of the claims translation | 2012-12-27 |
| (86) | Number | PCT/US2007/075401 |
| Date | 2007-08-07 |
| (87) | Number | WO 2008/019376 |
| Date | 2008-02-14 |
| (30) | Number | Date | Country code |
| 836250 P | 2006-08-07 | US | |
| 856144 P | 2006-11-01 | US |
| (72) |
AFAR, Daniel, US
|
| (73) |
AbbVie Biotherapeutics Inc.,
1500 Seaport Boulevard, Redwood City, CA 94063,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kompozicijos ir būdai, naudojant anti-CS1 antikūnus daugybinės mielomos gydymui |
| COMPOSITIONS AND METHODS USING ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE MYELOMA |
| Payment date | Validity (years) | Amount | |
| 2025-07-10 | 19 | 347.00 EUR |
| 2026-08-07 |